Has anyone tried Suzetrigine for pain hyperacusis or noxacusis? It is being distributed as JOURNAVX by Vertex Pharmaceuticals and was previously labeled VX-548 during clinical trials.
The FDA approved it on January 30, 2025. It targets moderate to severe pain by blocking pain signals in the...